BINEX Co. Ltd (053030) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, BINEX Co. Ltd (053030) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.62 Billion ≈ $2.45 Million USD) by net assets (₩187.21 Billion ≈ $126.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 053030 equity financing ratio to measure how much of total assets are equity-financed.

BINEX Co. Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how BINEX Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 053030 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

BINEX Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BINEX Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guardian Capital Group Limited TO:GCG	0.049x
Banco Alfa de Investimento S.A SA:BRIV3	-1.114x
Shandong Jining Ruyi Woolen Textile Co Ltd SHE:002193	-0.011x
Inclusio Sca BR:INCLU	0.002x
Shimmick Corporation Common Stock NASDAQ:SHIM	-0.011x
AMREP Corporation NYSE:AXR	0.039x
Bajaj Healthcare Limited NSE:BAJAJHCARE	0.094x
CHOROKBAEM COMPANY Co. Ltd KQ:052300	0.032x

Annual Cash Flow Conversion Efficiency for BINEX Co. Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of BINEX Co. Ltd from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see 053030 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩181.61 Billion ≈ $123.07 Million	₩-9.43 Billion ≈ $-6.39 Million	-0.052x	-349.11%
2023-12-31	₩181.33 Billion ≈ $122.88 Million	₩3.78 Billion ≈ $2.56 Million	0.021x	-76.60%
2022-12-31	₩191.61 Billion ≈ $129.85 Million	₩17.06 Billion ≈ $11.56 Million	0.089x	-42.77%
2021-12-31	₩180.42 Billion ≈ $122.27 Million	₩28.07 Billion ≈ $19.02 Million	0.156x	+35.30%
2020-12-31	₩173.22 Billion ≈ $117.39 Million	₩19.92 Billion ≈ $13.50 Million	0.115x	+71.13%
2019-12-31	₩160.50 Billion ≈ $108.77 Million	₩10.78 Billion ≈ $7.31 Million	0.067x	-25.95%
2018-12-31	₩149.43 Billion ≈ $101.27 Million	₩13.56 Billion ≈ $9.19 Million	0.091x	+43.61%
2017-12-31	₩128.75 Billion ≈ $87.25 Million	₩8.14 Billion ≈ $5.51 Million	0.063x	+133.80%
2016-12-31	₩140.55 Billion ≈ $95.25 Million	₩3.80 Billion ≈ $2.57 Million	0.027x	+186.63%
2015-12-31	₩144.14 Billion ≈ $97.68 Million	₩-4.50 Billion ≈ $-3.05 Million	-0.031x	-64.56%
2013-12-31	₩97.45 Billion ≈ $66.04 Million	₩-1.85 Billion ≈ $-1.25 Million	-0.019x	-206.41%
2011-12-31	₩70.58 Billion ≈ $47.83 Million	₩1.26 Billion ≈ $852.26K	0.018x	-80.30%
2007-12-31	₩34.50 Billion ≈ $23.38 Million	₩3.12 Billion ≈ $2.11 Million	0.090x	+14.74%
2006-12-31	₩31.91 Billion ≈ $21.62 Million	₩2.52 Billion ≈ $1.70 Million	0.079x	+54.89%
2005-12-31	₩28.99 Billion ≈ $19.64 Million	₩1.48 Billion ≈ $999.86K	0.051x	--

About BINEX Co. Ltd

KQ:053030 Korea Pharmaceuticals

Market Cap

$134.63 Million

₩198.67 Billion KRW

Market Cap Rank

#18034 Global

#742 in Korea

Share Price

₩6370.00

Change (1 day)

-2.90%

52-Week Range

₩6370.00 - ₩18490.00

All Time High

₩36100.00